by October Gallery
HONG KONG (Reuters) – China’s Huawei is set to reward employee shareholders with a 3 percent rise in cash dividends that are worth billions of dollars, according to company sources…
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to…
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular…
BRASILIA (Reuters) – Brazil’s health agency has concluded a re-evaluation of the safety of the weedkiller glyphosate, the most widely-used agriculture chemical in the country, and will present the findings…
WASHINGTON (Reuters) – U.S. and Chinese negotiators met for over seven hours on Saturday to resolve their trade dispute and avoid an escalation of the tit-for-tat tariffs that have already…
WASHINGTON (Reuters) – President Donald Trump said on Friday there was “a very good chance” the United States would strike a deal with China to end their trade war and…
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth a price of $310,000 to $900,000, according to an independent…
FILE PHOTO: The logo of Huawei Technologies in front of the German headquarters of the Chinese telecommunications group in Duesseldorf, Germany, February 18, 2019. REUTERS/Wolfgang Rattay/File Photo MILAN (Reuters) –…
HONG KONG (Reuters) – Several cryptocurrency exchanges have moved closer to mainstream markets by buying listed companies, looking to raise funds and present themselves as embedded in the traditional financial…
WASHINGTON (Reuters) – Top U.S. and Chinese trade negotiators haggled on Thursday over the details of a set of agreements aimed at ending their trade war, just one week before…